Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Int J Antimicrob Agents ; 64(4): 107299, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39142419

ABSTRACT

Neisseria gonorrhoeae is a global threat to public health due to the accumulation of antimicrobial resistance mechanisms. ST-1901 is an internationally important sequence type (ST) because of its high incidence and the usual occurrence of chromosomally determined resistance. In this study, we describe the evolution of the ST-1901 and its single locus variants in Rio de Janeiro from 2006 to 2022. We analyzed 82 N. gonorrhoeae isolates according to antimicrobial susceptibility profile, resistance mechanisms, molecular typing, and phylogenetics. Six different single locus variants were detected. Phylogenetic analysis identified five clades, which share similar characteristics. Resistance rates for penicillin and tetracycline decreased due to the lower occurrence of resistance plasmids, but intermediary resistance to penicillin rose. Resistance to ciprofloxacin remained high throughout all clades and the years of the study. Regarding resistance to azithromycin, alterations in mtrR promoter and gene, and 23S rRNA encoding gene rrl were detected, with a notable rise in the incidence of C2611T mutations in more recent years occurring in four of five clades. In contrast, ß-lactam resistance associated penA 34 mosaic was found only in one persisting clade (Clade D), and unique G45D and A39T mutations in mtrR gene and its promoter (Nm-Like) were found only in Clade B. Taken together, these data suggest that ST-1901, a persistently circulating lineage of N. gonorrhoeae in Rio de Janeiro, has undergone changes over the years and may evolve to develop resistance to the current recommended dual therapy adopted in Brazil, namely, ceftriaxone and azithromycin.


Subject(s)
Anti-Bacterial Agents , Gonorrhea , Microbial Sensitivity Tests , Neisseria gonorrhoeae , Phylogeny , Neisseria gonorrhoeae/genetics , Neisseria gonorrhoeae/drug effects , Neisseria gonorrhoeae/classification , Brazil , Anti-Bacterial Agents/pharmacology , Humans , Gonorrhea/microbiology , Gonorrhea/epidemiology , Gonorrhea/drug therapy , Drug Resistance, Bacterial/genetics , Bacterial Proteins/genetics , Azithromycin/pharmacology , Ciprofloxacin/pharmacology , RNA, Ribosomal, 23S/genetics , Repressor Proteins/genetics , Plasmids/genetics , Mutation , Penicillins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL